The effects of 2,3-dimercaptopropanol (BAL) on toxicity and excretion of gold. 1947

W C KUZELL, and P L PILLSBURY, and S A GELLERT

UI MeSH Term Description Entries
D001826 Body Fluids Liquid components of living organisms. Body Fluid,Fluid, Body,Fluids, Body
D004112 Dimercaprol An anti-gas warfare agent that is effective against Lewisite (dichloro(2-chlorovinyl)arsine) and formerly known as British Anti-Lewisite or BAL. It acts as a chelating agent and is used in the treatment of arsenic, gold, and other heavy metal poisoning. 2,3-Dimercaptopropanol,2,3-Dithiopropan-1-o1,B.A.L.,BAL in Oil,British Anti-Lewisite,British Anti-Lewisite Agent,Cadmium 2,3-Dimercaptopropanol,Dicaptol,2,3 Dimercaptopropanol,2,3 Dithiopropan 1 o1,2,3-Dimercaptopropanol, Cadmium,Anti-Lewisite Agent, British,Anti-Lewisite, British,British Anti Lewisite,British Anti Lewisite Agent,Cadmium 2,3 Dimercaptopropanol,Oil, BAL in,in Oil, BAL
D006046 Gold A yellow metallic element with the atomic symbol Au, atomic number 79, and atomic weight 197. It is used in jewelry, goldplating of other metals, as currency, and in dental restoration. Many of its clinical applications, such as ANTIRHEUMATIC AGENTS, are in the form of its salts.
D001692 Biological Transport The movement of materials (including biochemical substances and drugs) through a biological system at the cellular level. The transport can be across cell membranes and epithelial layers. It also can occur within intracellular compartments and extracellular compartments. Transport, Biological,Biologic Transport,Transport, Biologic
D017612 Gold Compounds Inorganic compounds that contain gold as an integral part of the molecule. Compounds, Gold
D050607 Organogold Compounds Organic compounds that contain GOLD as an integral part of the molecule. Some are used as ANTIRHEUMATIC AGENTS. The term chrysotherapy derives from an ancient Greek term for gold. Compounds, Organogold

Related Publications

W C KUZELL, and P L PILLSBURY, and S A GELLERT
November 1947, The Journal of laboratory and clinical medicine,
W C KUZELL, and P L PILLSBURY, and S A GELLERT
August 1946, The Journal of pharmacology and experimental therapeutics,
W C KUZELL, and P L PILLSBURY, and S A GELLERT
March 1947, Journal of the American Medical Association,
W C KUZELL, and P L PILLSBURY, and S A GELLERT
June 1950, Annals of the rheumatic diseases,
W C KUZELL, and P L PILLSBURY, and S A GELLERT
December 1953, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.),
W C KUZELL, and P L PILLSBURY, and S A GELLERT
July 1946, The Journal of clinical investigation,
W C KUZELL, and P L PILLSBURY, and S A GELLERT
April 1968, British journal of industrial medicine,
W C KUZELL, and P L PILLSBURY, and S A GELLERT
July 1946, The Journal of clinical investigation,
W C KUZELL, and P L PILLSBURY, and S A GELLERT
July 1946, The Journal of clinical investigation,
W C KUZELL, and P L PILLSBURY, and S A GELLERT
August 1946, The Journal of pharmacology and experimental therapeutics,
Copied contents to your clipboard!